Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management?

Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management?

Detalles Bibliográficos
Main Authors:	Conrad, N, McInnes, IB, Mcmurray, JJV, Sattar, N
Formato:	Journal article
Idioma:	English
Publicado:	BMJ Publishing 2022

Títulos similares

Review of the European League Against Rheumatism (EULAR) guidelines considered in 2018
por: T. V. Beketova
Publicado: (2019-05-01)

ACCORDING TO THE MATERIALS OF THE 2015/2016 NEW EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR) GUIDELINES FOR REDUCING CARDIOVASCULAR RISK IN PATIENTS WITH INFLAMMATORY ARTHRITIS: GENERAL CHARACTERIZATION AND DISCUSSION PROBLEMS
por: T. V. Popkova, et al.
Publicado: (2018-07-01)

According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
por: T. V. Popkova, et al.
Publicado: (2019-11-01)

EULAR recommendations on the management of systemic qlucocorticoid therapy in Rheumatic diseases
por: Y. Jakods, et al.
Publicado: (2016-05-01)

Cardiovascular risk in systemic autoimmune diseases – authors' reply
por: Conrad, N, et al.
Publicado: (2023)

Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations
por: E. S. Aronova, et al.
Publicado: (2024-06-01)

Vaccination in Rheumatology: New Data (Based on Recommendations of the European League Against Rheumatism)
por: B. S. Belov, et al.
Publicado: (2020-05-01)

Gout and incidence of 12 cardiovascular diseases: a case–control study including 152 663 individuals with gout and 709 981 matched controls
por: Ferguson, LD, et al.
Publicado: (2024)

The new 2019 American college of rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for IgG4-related disease
por: E. V. Sokol
Publicado: (2020-09-01)

AT-RISK: AuToimmune disorders and cardiovascular RISK
por: Conrad, N, et al.
Publicado: (2022)

SUBCLINICAL CARDIOVASCULAR SYSTEM INVOLVEMENT IN RHEUMATIC DISEASES
por: A. L. Maslyansky, et al.
Publicado: (2015-05-01)

RISK FACTORS OF EARLY CARDIOVASCULAR PATHOLOGY OF CHILDREN SUFFERING FROM JUVENILE RHEUMATIC ARTHRITIS
por: E.Yu. Gudkova, et al.
Publicado: (2007-09-01)

Chronic and opportunistic infections in patients with immuno-inflammatory rheumatic diseases: screening and prevention issues (based on the materials of the EULAR recommendations)
por: B. S. Belov, et al.
Publicado: (2023-03-01)

European League Against Rheumatism recommendations for terminologyand diagnosis of calcium pyrophosphate crystal deposition disease: Expert comment
por: V G Barskova, et al.
Publicado: (2011-06-01)

European League Against Rheumatism recommendations for terminology and diagnosis of calcium pyrophosphate crystal deposition disease: An expert's comments
por: Viktoriya Georgievna Barskova, et al.
Publicado: (2011-09-01)

CARDIOVASCULAR EFFECTS OF SELECTIVE COX-2 INHIBITORS IN RHEUMATIC DISEASES
por: Rimma Mikhailovna Balabanova
Publicado: (2010-06-01)

Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases
por: Morena Scotece, et al.
Publicado: (2012-01-01)

Echocardiography in Autoimmune Rheumatic Diseases for Diagnosis and Prognosis of Cardiovascular Complications
por: George Makavos, et al.
Publicado: (2020-09-01)

Acute Rheumatic Fever and Rheumatic Heart Disease: Highlighting the Role of Group A Streptococcus in the Global Burden of Cardiovascular Disease
por: Tangeni Auala, et al.
Publicado: (2022-04-01)

Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
por: Susanne Pettersson, et al.
Publicado: (2023-11-01)

Perioperative Management of Patients with Rheumatic Disease: Cardiovascular Risks, Prevention of Infectious and Thromboembolic Complications, Other Conditions
por: V. A. Lyalina, et al.
Publicado: (2022-05-01)

Characterisation of cardiovascular involvement in inflammatory arthropathies and systemic rheumatic diseases using multi-parametric cardiovascular magnetic resonance
por: Ntusi, N, et al.
Publicado: (2013)

Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
Publicado: (2023-08-01)

Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases
por: Rossana Scrivo, et al.
Publicado: (2013-01-01)

Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
por: Conrad, N, et al.
Publicado: (2022)

Correction: Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases
Publicado: (2023-10-01)

American College of Rheumatology and European League Against Rheumatism 2017 Provisional Classification Criteria for Granulomatosis with Polyangiitis
por: Grayson, PC, et al.
Publicado: (2017)

Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
por: Hsin-Hua Chen, et al.
Publicado: (2018-01-01)

PREVENTION OF RHEUMATIC HEART DISEASE AND RHEUMATIC FEVER
por: Namrata Khanal
Publicado: (2003-01-01)

Risk factors for severe COVID-19 in patients with rheumatic diseases
por: A. N. Kulikov, et al.
Publicado: (2024-03-01)

Acute rheumatic fever and rheumatic heart disease: what's new?
por: D. Yu. Andriyashkina, et al.
Publicado: (2023-08-01)

Eular recommendations for vasculitis
por: Luqmani, R, et al.
Publicado: (2007)

Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases
por: Ntusi, N, et al.
Publicado: (2018)

Risk Assessment and Optimization for Pregnancy in Patients with Rheumatic Diseases
por: Alyssa Kwok
Publicado: (2024-07-01)

NON-RHEUMATIC MYOCARDITIDES
por: N. A. Shostak, et al.
Publicado: (2015-10-01)

Fibroblastic rheumatism
por: Jyoti Ranjan Parida
Publicado: (2017-01-01)

Rheumatic manifestations of hypothyroidism
por: L. V. Teplova, et al.
Publicado: (2017-04-01)

Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum
por: Joselyn Rwebembera, et al.
Publicado: (2022-01-01)

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
por: Dasgupta, B, et al.
Publicado: (2012)

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
por: Dasgupta, B, et al.
Publicado: (2012)